Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains uncertain. The purpose of this study was to compare the efficacy and safety of ticagrelor and clopidogrel in East Asian patients with CAD treated with PCI.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Curr Med Res Opin

Title: Current medical research and opinion

Publisher: Informa UK Limited

ISSN (Electronic): 1473-4877

ISSN (Print): 0300-7995

Publication date (Electronic): November 2020

Volume: 36

Issue: 11

Affiliations

[1 ] Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Article

DOI: 10.1080/03007995.2020.1825364

PubMed ID: 32945695

SO-VID: 8b3b8584-635e-4291-9304-964bc7293836

History

Keywords: East Asian,Ticagrelor,clopidogrel,coronary artery disease,percutaneous coronary intervention

Data availability:

Keywords: East Asian, Ticagrelor, clopidogrel, coronary artery disease, percutaneous coronary intervention

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 5

See all cited by